Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2026)
Sanara MedTech's (SMTI) quarterly Income from Non-Controlling Interests came in at -$354.0 in Q1 2026, down 71.84% YoY from -$1257.3 in Q1 2025, and down 45.08% on a QoQ basis from -$244.0 in Q4 2025.
Sanara MedTech (SMTI) Income from Non-Controlling Interests (2019 - 2026) Analysis & Trends
Sanara MedTech (SMTI) has 8 years of Income from Non-Controlling Interests data on file, last reported at -$354.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests fell 71.84% year-over-year to -$354.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5589.0 (up 98.08% YoY) and the FY2025 annual result came in at -$5441.0, up 97.77% from the prior year.
- Income from Non-Controlling Interests declined to -$354.0 in Q1 2026, from -$244.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $242000.0 in Q4 2022 to a low of -$240903.0 in Q4 2024.
- A 5-year average of -$19130.5 and a median of -$25250.0 in 2023 frame the typical range for Income from Non-Controlling Interests.
- Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests jumped 3023.76% — and 2024, when it tumbled 854.07%.
- Tracing SMTI's Income from Non-Controlling Interests over 5 years: stood at $242000.0 in 2022, then plunged by 110.43% to -$25250.0 in 2023, then plunged by 854.07% to -$240903.0 in 2024, then soared by 99.9% to -$244.0 in 2025, then tumbled by 45.08% to -$354.0 in 2026.
- The last three Income from Non-Controlling Interests figures came in at -$354.0 (Q1 2026), -$244.0 (Q4 2025), and -$955.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 6.60 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 79.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | - |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | - |
| 10 | Sanara MedTech | 297.82 Mn | 297.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -354.00 |
| Dec 31, 2025 | -244.00 |
| Sep 30, 2025 | -955.00 |
| Jun 30, 2025 | -4,036.00 |
| Mar 31, 2025 | -206.00 |
| Dec 31, 2024 | -240,903.00 |
| Sep 30, 2024 | -25,284.00 |
| Jun 30, 2024 | -25,188.00 |
| Mar 31, 2024 | -34,859.00 |
| Dec 31, 2023 | -25,250.00 |
| Sep 30, 2023 | -34,579.00 |
| Jun 30, 2023 | -38,447.00 |
| Mar 31, 2023 | -38,429.00 |
| Dec 31, 2022 | 242,000.00 |
| Sep 30, 2022 | -58,792.00 |
| Jun 30, 2022 | -12,512.00 |
| Mar 31, 2022 | -27,181.00 |
| Dec 31, 2021 | -8,277.00 |
| Sep 30, 2021 | -27,491.00 |
| Jun 30, 2021 | -34,481.00 |